ATE513818T1 - Chinazolinonderivate als tubulinpolymerisationshemmer - Google Patents
Chinazolinonderivate als tubulinpolymerisationshemmerInfo
- Publication number
- ATE513818T1 ATE513818T1 AT09724207T AT09724207T ATE513818T1 AT E513818 T1 ATE513818 T1 AT E513818T1 AT 09724207 T AT09724207 T AT 09724207T AT 09724207 T AT09724207 T AT 09724207T AT E513818 T1 ATE513818 T1 AT E513818T1
- Authority
- AT
- Austria
- Prior art keywords
- tubulin polymerization
- polymerization inhibitors
- quinazolinone derivatives
- formula
- inhibitors
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08153428 | 2008-03-27 | ||
PCT/EP2009/053604 WO2009118384A1 (en) | 2008-03-27 | 2009-03-26 | Quinazolinone derivatives as tubulin polymerization inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE513818T1 true ATE513818T1 (de) | 2011-07-15 |
Family
ID=40445540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT09724207T ATE513818T1 (de) | 2008-03-27 | 2009-03-26 | Chinazolinonderivate als tubulinpolymerisationshemmer |
Country Status (8)
Country | Link |
---|---|
US (1) | US8168644B2 (de) |
EP (1) | EP2260026B1 (de) |
JP (1) | JP5464609B2 (de) |
AT (1) | ATE513818T1 (de) |
AU (1) | AU2009228945B2 (de) |
CA (1) | CA2716088C (de) |
ES (1) | ES2367760T3 (de) |
WO (1) | WO2009118384A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MA34591B1 (fr) | 2010-10-06 | 2013-10-02 | Glaxosmithkline Llc | Dérivés de benzimidazole utilisés comme inhibiteurs de pi3 kinase |
JP5781636B2 (ja) | 2011-03-14 | 2015-09-24 | インパクト セラピューティックス インコーポレイテッド | キナゾリンジオン及びその使用 |
TWI527800B (zh) | 2011-04-01 | 2016-04-01 | 南京英派藥業有限公司 | 作為聚(二磷酸腺苷酸-核醣)聚合酶(parp)之抑制劑之1-(芳基甲基)喹唑啉-2,4(1h,3h)-二酮及其應用 |
US9719970B2 (en) | 2012-11-30 | 2017-08-01 | Waters Technologies Corporation | Methods and apparatus for the analysis of vitamin D metabolites |
KR20150141971A (ko) * | 2013-04-08 | 2015-12-21 | 파마싸이클릭스 엘엘씨 | 이브루티닙 병용 요법 |
US11945691B2 (en) * | 2017-01-31 | 2024-04-02 | Inventio Ag | Elevator with a monitoring arrangement for monitoring an integrity of suspension members |
JP7372253B2 (ja) | 2018-04-05 | 2023-10-31 | ノビガ・リサーチ・エービー | 癌の治療における使用のためのチューブリン重合阻害剤とポリ(adp-リボース)ポリメラーゼ(parp)阻害剤との新規組合せ |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1006423B (de) | 1952-01-18 | 1957-04-18 | Ciba Geigy | Verfahren zur Herstellung von Hydrazinophthalazinen |
GB732581A (en) | 1952-01-18 | 1955-06-29 | Ciba Ltd | Manufacture of hydrazine compounds |
US3274194A (en) * | 1963-03-29 | 1966-09-20 | Miles Lab | Quinazolinedione derivatives |
GB1062357A (en) | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
GB1293565A (en) * | 1969-05-03 | 1972-10-18 | Aspro Nicholas Ltd | Aminophthalazines and pharmaceutical compositions thereof |
US3919425A (en) * | 1971-04-09 | 1975-11-11 | Miles Lab | Method of producing vasodilation using certain 3-substituted-quinazoline derivatives |
BE792206A (de) | 1971-12-02 | 1973-06-01 | Byk Gulden Lomberg Chem Fab | |
FR2436781A1 (fr) | 1978-09-19 | 1980-04-18 | Berri Balzac | Derives d'amino-3 (1h,3h) quinazolinedione-2,4, leur procede de preparation et leurs applications en therapeutique |
US4335127A (en) * | 1979-01-08 | 1982-06-15 | Janssen Pharmaceutica, N.V. | Piperidinylalkyl quinazoline compounds, composition and method of use |
JPS5976082A (ja) | 1982-10-23 | 1984-04-28 | Kyowa Hakko Kogyo Co Ltd | 新規なピペリジン誘導体 |
JPS60120872A (ja) | 1983-12-01 | 1985-06-28 | Kyowa Hakko Kogyo Co Ltd | 新規なヘテロ環状化合物及び強心剤 |
ZM1785A1 (en) | 1984-03-26 | 1986-03-27 | Janssen Pharmaceutica Nv | Anti-virally active phyridazinamines |
US5001125A (en) | 1984-03-26 | 1991-03-19 | Janssen Pharmaceutica N.V. | Anti-virally active pyridazinamines |
DK623586A (da) * | 1985-12-27 | 1987-06-28 | Eisai Co Ltd | Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne |
US5231184A (en) * | 1987-11-23 | 1993-07-27 | Janssen Pharmaceutica N.V. | Pridazinamine derivatives |
US5177075A (en) * | 1988-08-19 | 1993-01-05 | Warner-Lambert Company | Substituted dihydroisoquinolinones and related compounds as potentiators of the lethal effects of radiation and certain chemotherapeutic agents; selected compounds, analogs and process |
GB8827822D0 (en) * | 1988-11-29 | 1988-12-29 | Janssen Pharmaceutica Nv | (1h-azol-1-ylmethyl)substituted quinoline derivatives |
CA2002864C (en) | 1988-11-29 | 1999-11-16 | Eddy J. E. Freyne | (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives |
US5374637A (en) * | 1989-03-22 | 1994-12-20 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives |
EP0391462A1 (de) | 1989-04-05 | 1990-10-10 | Janssen Pharmaceutica N.V. | Ketanserin enthaltende synergistische Zusammensetzungen |
US5160727A (en) | 1990-02-13 | 1992-11-03 | Warner-Lambert Company | Tumor cell sensitization method using quinazolinedione derivatives |
IE913473A1 (en) * | 1990-10-15 | 1992-04-22 | Fujisawa Pharmaceutical Co | Quinazoline derivatives and their preparation |
CA2134077C (en) | 1992-04-23 | 2002-05-21 | Thaddeus R. Nieduzak | 4-imidomethyl-1-[2'phenyl-2'oxoethyl-]piperidines as serotonin 5ht2-antagonists, their preparation and use in therapy |
TW294595B (de) | 1992-11-20 | 1997-01-01 | Janssen Pharmaceutica Nv | |
EP0638567A4 (de) | 1993-02-18 | 1995-05-10 | Kyowa Hakko Kogyo Kk | Adenosin-aufnahme inhibitoren. |
GB9404485D0 (en) | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
TW445263B (en) | 1996-02-29 | 2001-07-11 | Janssen Pharmaceutica Nv | Novel esters of 1,4-disubstituted piperidine derivatives |
JPH107572A (ja) | 1996-06-17 | 1998-01-13 | Sumitomo Pharmaceut Co Ltd | 腫瘍壊死因子産生阻害剤 |
EA004037B1 (ru) | 1996-09-10 | 2003-12-25 | Др. Карл Томэ ГмбХ | Модифицированные аминокислоты и лекарственное средство на их основе |
WO1998054135A1 (fr) * | 1997-05-30 | 1998-12-03 | Meiji Seika Kaisha, Ltd. | Composes heterocycliques azotes et medicament contre l'hyperlipemie en contenant |
JPH10330377A (ja) | 1997-06-02 | 1998-12-15 | Kyowa Hakko Kogyo Co Ltd | ピペリジン誘導体 |
US6635642B1 (en) * | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
WO1999014203A1 (fr) | 1997-09-16 | 1999-03-25 | Takeda Chemical Industries, Ltd. | Composes azotes a cycles condenses, procede de preparation de ces composes et medicaments |
US6133277A (en) | 1997-12-05 | 2000-10-17 | Janssen Pharmaceutica N.V. | (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties |
JP2000191659A (ja) | 1999-01-04 | 2000-07-11 | Sumitomo Pharmaceut Co Ltd | 腫瘍壊死因子産生阻害剤 |
BR0007664A (pt) | 1999-01-29 | 2002-05-07 | Abbott Lab | Derivados diazabicìclicos como ligantes receptores de acetilcolina nicotìnicos |
US7265115B2 (en) * | 1999-01-29 | 2007-09-04 | Abbott Laboratories | Diazabicyclic CNS active agents |
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
UA76726C2 (uk) * | 2000-10-02 | 2006-09-15 | Янссен Фармацевтика Н.В. | Метаботропічні антагоністи рецептора глутамату, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб її одержання |
ITMI20002358A1 (it) | 2000-10-31 | 2002-05-01 | Flavio Moroni | Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi |
AUPR201600A0 (en) | 2000-12-11 | 2001-01-11 | Fujisawa Pharmaceutical Co., Ltd. | Quinazolinone derivative |
JP2002284699A (ja) | 2001-03-28 | 2002-10-03 | Sumitomo Pharmaceut Co Ltd | 視細胞変性疾患治療剤 |
EP1396488A1 (de) * | 2001-05-23 | 2004-03-10 | Mitsubishi Pharma Corporation | Kondensierte heterocyclische verbindung und deren medizinische verwendung |
WO2003015785A1 (en) | 2001-08-15 | 2003-02-27 | Icos Corporation | 2h-phthalazin-1-ones and methods for use thereof |
US7060705B2 (en) | 2001-11-07 | 2006-06-13 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
AUPR975601A0 (en) | 2001-12-24 | 2002-01-31 | Fujisawa Pharmaceutical Co., Ltd. | Quinazolinone derivatives |
AUPS137402A0 (en) | 2002-03-26 | 2002-05-09 | Fujisawa Pharmaceutical Co., Ltd. | Novel tricyclic compounds |
MXPA04009435A (es) | 2002-03-29 | 2005-01-25 | Janssen Pharmaceutica Nv | Derivados de quinolina y quinolinona radiomarcados y su uso como ligandos de receptor de glutamato metabotropico. |
US7119111B2 (en) * | 2002-05-29 | 2006-10-10 | Amgen, Inc. | 2-oxo-1,3,4-trihydroquinazolinyl derivatives and methods of use |
US20050075364A1 (en) | 2003-07-01 | 2005-04-07 | Kap-Sun Yeung | Indole, azaindole and related heterocyclic N-substituted piperazine derivatives |
SG150534A1 (en) * | 2003-11-20 | 2009-03-30 | Janssen Pharmaceutica Nv | 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp- ribose) polymerase inhibitors |
KR101118582B1 (ko) | 2003-11-20 | 2012-02-27 | 얀센 파마슈티카 엔.브이. | 폴리(adp-리보스)폴리머라제 저해제로서의 6-알케닐 및6-페닐알킬 치환된 2-퀴놀리논 및 2-퀴녹살리논 |
AU2004294354B2 (en) | 2003-12-03 | 2009-02-19 | Ym Biosciences Australia Pty Ltd | Tubulin inhibitors |
ES2551299T3 (es) | 2003-12-05 | 2015-11-17 | Janssen Pharmaceutica Nv | 2-Quinolinonas y 2-quinoxalinonas 6-sustituidas como inhibidores de poli(ADP-ribosa) polimerasa |
UA91007C2 (ru) | 2003-12-10 | 2010-06-25 | Янссен Фармацевтика Н.В. | Замещенные 6-циклогексилалкилом замещенные 2-хинолиноны и 2-хиноксалиноны как ингибиторы поли-(адф-рибоза)полимеразы |
PE20060285A1 (es) | 2004-03-30 | 2006-05-08 | Aventis Pharma Inc | Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp) |
CN1988907B (zh) * | 2004-06-01 | 2010-12-22 | 弗吉尼亚大学专利基金会 | 癌瘤及血管生成的双重小分子抑制剂 |
ES2563954T3 (es) | 2004-06-30 | 2016-03-16 | Janssen Pharmaceutica Nv | Derivados de ftalazina como inhibidores de PARP |
CA2569826C (en) | 2004-06-30 | 2013-07-16 | Janssen Pharmaceutica N.V. | Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
CA2569827C (en) * | 2004-06-30 | 2013-04-09 | Janssen Pharmaceutica N.V. | Quinazolinedione derivatives as parp inhibitors |
JP5123671B2 (ja) | 2005-02-17 | 2013-01-23 | シンタ ファーマシューティカルズ コーポレーション | 増殖性疾患の治療のための化合物 |
JP5075624B2 (ja) * | 2005-04-28 | 2012-11-21 | 田辺三菱製薬株式会社 | シアノピリジン誘導体及びその医薬としての用途 |
EP1937268A4 (de) | 2005-08-24 | 2009-07-22 | Inotek Pharmaceuticals Corp | Indenoisochinolinon-analoga und anwendungsverfahren dafür |
EP1984333B1 (de) | 2006-02-03 | 2012-04-25 | Bionomics Limited | Substituierte benzofurane, benzothiophene, benzoselenophene und indole und ihre verwendung als tubulinpolymerisationsinhibitoren |
CN101421268B (zh) | 2006-02-15 | 2016-01-06 | Abbvie公司 | 作为有效parp抑制剂的吡唑并喹诺酮 |
US8466150B2 (en) * | 2006-12-28 | 2013-06-18 | Abbott Laboratories | Inhibitors of poly(ADP-ribose)polymerase |
ES2381446T3 (es) * | 2007-03-08 | 2012-05-28 | Janssen Pharmaceutica, N.V. | Derivado de quinolinona como inhibidores de PARP y TANK |
US8153633B2 (en) * | 2007-06-25 | 2012-04-10 | Amgen Inc. | Phthalazine compounds, compositions and methods of use |
-
2009
- 2009-03-26 WO PCT/EP2009/053604 patent/WO2009118384A1/en active Application Filing
- 2009-03-26 CA CA2716088A patent/CA2716088C/en active Active
- 2009-03-26 JP JP2011501235A patent/JP5464609B2/ja active Active
- 2009-03-26 US US12/934,733 patent/US8168644B2/en active Active
- 2009-03-26 ES ES09724207T patent/ES2367760T3/es active Active
- 2009-03-26 EP EP09724207A patent/EP2260026B1/de active Active
- 2009-03-26 AT AT09724207T patent/ATE513818T1/de not_active IP Right Cessation
- 2009-03-26 AU AU2009228945A patent/AU2009228945B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP5464609B2 (ja) | 2014-04-09 |
US8168644B2 (en) | 2012-05-01 |
CA2716088C (en) | 2017-03-07 |
EP2260026B1 (de) | 2011-06-22 |
ES2367760T3 (es) | 2011-11-08 |
EP2260026A1 (de) | 2010-12-15 |
CA2716088A1 (en) | 2009-10-01 |
US20110028433A1 (en) | 2011-02-03 |
JP2011515451A (ja) | 2011-05-19 |
WO2009118384A1 (en) | 2009-10-01 |
AU2009228945A1 (en) | 2009-10-01 |
AU2009228945B2 (en) | 2013-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE542799T1 (de) | Chinolinonderivate als parp und tank-inhibitoren | |
MX2010010406A (es) | Tetrahidrofenantridinonas y tetrahidrociclopentaquinolinonas como inhibidores de la polimerizacion de poli(adp-ribosa)polimerasa-1 y tubulina. | |
ATE547415T1 (de) | Inhibitoren der wechselwirkung zwischen mdm2 und p53 | |
SG154434A1 (en) | Quinazolinone derivatives as parp inhibitors | |
ATE470665T1 (de) | Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53 | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
ECSP10010722A (es) | Compuestos orgánicos | |
EA201070278A1 (ru) | Ингибиторы гамма-секретазы | |
EA201001359A1 (ru) | Гетероциклические соединения в качестве ингибиторов cxcr2 | |
BR112012008385A2 (pt) | inibidores de p13 cinase e uso dos mesmos. | |
TW200610531A (en) | Phthalazine derivatives as PARP inhibitors | |
MX2012002542A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina. | |
SG154432A1 (en) | Quinazolinedione derivatives as parp inhibitors | |
UA109775C2 (xx) | N-вмісні гетероарильні похідні як інгібітори jak3-кінази | |
CR20110028A (es) | Derivados de pirimidina como inhibidores de cinasa | |
EA201270590A1 (ru) | Ингибиторы акт | |
ATE513818T1 (de) | Chinazolinonderivate als tubulinpolymerisationshemmer | |
EA201071224A1 (ru) | Ингибиторы limk2, композиции, содержащие их, и способы их применения | |
UY30127A1 (es) | Derivados de acidos antranilicos fenoxi y feniltio, composiciones farmaceuticas que los contienen y su uso. | |
EA201170680A1 (ru) | Ингибиторы акт и p70 s6-киназы | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
EA201101334A1 (ru) | Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их | |
EA201200891A1 (ru) | Производные 3,4,4a,10d-тетрагидро-1h-тиопирано[4,3-c]изохинолина | |
JO2704B1 (en) | Interference inhibition factors between MD2 and B53 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |